Authors/Disclosures
|
Nicolas Dupre, MD, FAAN
(CHU de Quebec - U Laval)
|
Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation. |
|
Paul Valdmanis
|
No disclosure on file |
|
|
No disclosure on file |
|
Taylor Hall
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Isabelle Thiffault, PhD
(Center for the Study of Brain Diseases, CHUM)
|
No disclosure on file |
|
Bernard Brais, MD
|
Dr. Brais has nothing to disclose. |
|
Lyle E. Weston, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Guy A. Rouleau, MD, PhD, FAAN
(Montreal Neurological Institute and Hospital)
|
Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |